Comparative Analysis of Cost Effectiveness of Ceftriaxone and Cefotaxime Antibiotic Therapy in Inpatients with Typhoid Fever in Aulia Pandeglang Regional Hospital in 2023

Yusransyah Yusransyah; Risa Rustiyani; Agnes Wieanita Nurani; Sofi Nurmay Stiani; Baha Udin; Leni Halimatusyadiah

doi:10.52365/jecp.v5i2.1436

Comparative Analysis of Cost Effectiveness of Ceftriaxone and Cefotaxime Antibiotic Therapy in Inpatients with Typhoid Fever in Aulia Pandeglang Regional Hospital in 2023

Yusransyah Yusransyah, Risa Rustiyani, Agnes Wieanita Nurani, Sofi Nurmay Stiani, Baha Udin, Leni Halimatusyadiah

Abstract

Typhoid fever is still a significant health problem for children in developing countries, including Indonesia. This disease is caused by infection with Salmonella Typhi bacteria, which is a Gram-negative bacteria and requires treatment with antibiotics. The use of antibiotics usually takes up a large portion of the hospital treatment budget. This study aims to compare the cost-effectiveness between two types of antibiotics, namely ceftriaxone and cefotaxime, in typhoid fever patients at Aulia Pandeglang Hospital, and to find the most cost-efficient treatment. This study is descriptive and observational, with retrospective data collection. The data used came from medical records and cost records of inpatients with typhoid fever in children aged 1 to 11 years at Aulia Pandeglang Hospital in 2023. A total of 20 patients met the study criteria. The outcomes measured in this study were the average length of stay in the hospital. The cost components calculated consisted of direct medical costs, such as drug costs, action costs, inpatient costs, medical device costs, and laboratory fees. The analysis was conducted from the payer's perspective. The results showed that the cost for the effectiveness of using ceftriaxone and cefotaxime was IDR 15,264 and IDR 18,265, with an ICER of IDR 257.9 to increase the effectiveness of cefotaxime. The conclusion of this study is that ceftriaxone is a more cost-effective antibiotic.

Keywords

Typhoid fever; cost effectiveness; ceftriaxone; cefotaxime

Full Text:

PDF

References

Adisasmito, Amar W. 2016. “Penggunaan Antibiotik pada Terapi Demam Tifoid Anak di RSAB Harapan Kita.” Sari Pediatri 8 (3): 174. https://doi.org/10.14238/sp8.3.2006.174-80.

Agnes, Agatha, Gayatri Citraningtyas, and Sri Sudewi. 2019. “Analisis Efektivitas Biaya pada Pasien Gastritis Rawat Inap di Rumah Sakit Bhayangkara Manado.” Pharmacon 8 (4): 767. https://doi.org/10.35799/pha.8.2019.29351.

Akhyani, Nur, Risma Sakti Pambudi, Khotimatul Khusna, Program Studi Farmasi, Fakultas Sains, and Universitas Sahid Surakarta. 2024. “Efektivitas Biaya Antibiotik pada Pasien Demam Tifoid di Klinik X Sragen” 20 (4): 549–57. https://doi.org/10.22146/farmaseutik.v20i4.85941.

Andayani, and Arulita Fibriana. 2018. “Kejadian Demam Tifoid di Wilayah Kerja Puskesmas Karangmalang.” HIGEIA Journal of Public Health Research and DevelopmentJ 2 (1): 57–68. http://journal.unnes.ac.id/sju/index.php/higeia.

Bhandari, Jenish, Pawan K. Thada, Muhammad F. Hashmi, and Elizabeth DeVos. 2024. “Typhoid Fever.” Treasure Island (FL): StatPearls Publishing. 2024. https://www.ncbi.nlm.nih.gov/books/NBK557513/.

Hidayah, Shofi Nurul, Abdul Hakim, Ach Syahrir, and Wirda Anggraini. 2020. “Analisis Efektivitas Biaya Seftriakson dan Sefotaksim pada Pasien Demam Tifoid Anak di Instalasi Rawat Inap Shofa dan Marwah PKU Karangasem Muhammadiyah Paciran Tahun 2019.” Journal of Islamic Pharmacy 5 (2): 46–52. https://doi.org/10.18860/jip.v5i2.9819.

Idrus, Hasta Handayani, Nurfika Utami, Rahmawati Rahmawati, Indah Lestari Daeng Kanang, Inna Mutmainnah Musa, and Rasfayanah Rasfayanah. 2023. “Analisis Penggunaan Antibiotik Pasien Demam Tifoid dengan Komplikasi dan Tanpa Komplikasi yang dirawat di Rumah Sakit.” UMI Medical Journal 8 (1): 46–52. https://doi.org/10.33096/umj.v8i1.242.

Jannah, Nurul, Ihwan, and M. Rinaldhi Tandah. 2019. “Efektifitas Biaya Penggunaan Seftriakson dan Sefiksim pada Pasien Demam Tifoid Rawat Inap di RSU Anutapura Palu Periode 2015-2017.” Jurnal Ilmiah Medicamento 5 (1): 45–50. https://doi.org/10.36733/medicamento.v5i1.842.

Kementrian Kesehatan RI. 2013. Pedoman Penerapan Kajian Farmakoekonomi. Jakarta: Kementerian Kesehatan RI.

Mahendradhata, Yodi, Laksono Trisnantoro, Shita Listyadewi, Prastuti Soewondo, Tiara Marthias, Pandu Harimurti, and John Prawira. 2017. The Republic of Indonesia Health System Review. Vol. 7. https://iris.who.int/handle/10665/254716.

Marasine, Nirmal Raj, Shakti Shrestha, Sabina Sankhi, Nabina Paudel, Ashish Gautam, and Arjun Poudel. 2021. “Antibiotic Utilization, Sensitivity, and Cost in the Medical Intensive Care Unit of a Tertiary Care Teaching Hospital in Nepal.” SAGE Open Medicine 9. https://doi.org/10.1177/20503121211043710.

Marseille, Elliot, Bruce Larson, Dhruv S. Kazi, James G. Kahn, and Sydney Rosen. 2015. “Thresholds for the Cost–Effectiveness of Interventions: Alternative Approaches.” Bulletin of the World Health Organization 93 (2): 118–24. https://doi.org/10.2471/BLT.14.138206.

Mas-Dalmau, Gemma, María José Pérez-Lacasta, Pablo Alonso-Coello, Pedro Gorrotxategi-Gorrotxategi, Emma Argüelles-Prendes, Oscar Espinazo-Ramos, Teresa Valls-Duran, et al. 2023. “A Trial-Based Cost-Effectiveness Analysis of Antibiotic Prescription Strategies for Non-Complicated Respiratory Tract Infections in Children.” BMC Pediatrics 23 (1): 1–13. https://doi.org/10.1186/s12887-023-04235-3.

Musnelina, Lili, Celin Gracela Tanama, and Teodhora. 2024. “Cost-Effectiveness of Antibiotics for Typhoid Fever at Hermana Lembean Hospital Lili.” Journal of Tropical Pharmacy and Chemistry 8 (1): 58–64. https://doi.org/10.30872/j.trop.pharm.chem.v8i1.169.

Musthofa, Ali. 2021. “Literature Review Hubungan Pengetahuan Orang Tua Tentang Demam Tifoid dengan Kejadian Demam Tifoid Pada Anak.” J. Sehat Masada 15 (2): 9. https://doi.org/10.38037/jsm.v15i2.

Nuraini, Fuzna Avisha, Herry Garna, and Titik Respati. 2015. “Perbandingan Kloramfenikol dengan Seftriakson terhadap Lama Hari Turun Demam pada Anak Demam Tifoid.” Prosiding Pendidikan Dokter 4 (18): 914–19.

Otieku, Evans, Joergen Anders Lindholm Kurtzhals, Ama Pokuaa Fenny, Alex Owusu Ofori, Appiah Korang Labi, and Ulrika Enemark. 2024. “Healthcare Provider Cost of Antimicrobial Resistance in Two Teaching Hospitals in Ghana.” Health Policy and Planning 39 (2): 178–87. https://doi.org/10.1093/heapol/czad114.

Pinem, Agung Haganta, Rapael Ginting, Ali Napiah Nasution, and Ermi Girsang. 2021. “Analysis Cost Effectiveness of Antibiotic Usage in Typhoid Fever Patients in Hospital Royal Prima Medan.” Ijses.Com 5 (8): 9–12. http://ijses.com/wp-content/uploads/2021/08/120-IJSES-V5N7.pdf.

Pratiwi, Galih, Meri Rosita, and Khoirin. 2022. “Evaluasi Penggunaan Antibiotik pada Pasien Demam Tifoid dengan Metode ATC/DDD.” Babul Ilmi_Jurnal Ilmiah Multi Science Kesehatan 14 (2): 151–60. https://doi.org/10.36729/bi.v14i2.958.

Pratiwi, Rosaria Ika, and Anggy Rima Putri. 2022. “Perbandingan Efektivitas Ceftriaxone dan Cefotaxime pada Pasien Anak Demam Tifoid di Rumah Sakit Mitra Siaga.” Jurnal Ilmiah Manuntung 8 (1): 8–13. https://doi.org/10.51352/jim.v8i1.461.

Saito, Mari Kajiwara, Christopher M. Parry, and Shunmay Yeung. 2018. “Modelling the Cost-Effectiveness of a Rapid Diagnostic Test (IgMFA) for Uncomplicated Typhoid Fever in Cambodia.” PLoS Neglected Tropical Diseases 12 (11): 1–18. https://doi.org/10.1371/journal.pntd.0006961.

Sharma, Birendra, Raghuvendra Chalikwar, Sagar Bhalerao, Ajitkumar A Gondane, Dattatray Pawar, and Akhilesh Sharma. 2024. “Cefotaxime Versus Ceftriaxone: A Comprehensive Comparative Review.” Cureus 16 (9): e69146. https://doi.org/10.7759/cureus.69146.

Ujjan, Ahmed, Ghulam Serwar Shaikh, Soobia Pathan, Madiha Niamat, Faiza Shaikh, and Kashif Ali. 2024. “The Effectiveness of Azithromycin versus Cexime in the Treatment of Typhoid Fever in Children.” Pakistan Journal of Health Sciences 5 (10): 179–83. https://doi.org/10.54393/pjhs.v5i10.2105.

World Bank. 2023. “GDP per Capita (Current US$) - Indonesia.” World Bank. 2023. https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=ID.

Yusransyah, Deden Kurniawan, Baha Udin, and Nurul Insani. 2024. “Analysis of Cost Effectiveness of Antibiotic Use in Typhod Fever Patients At Kartini Rangkasbitung Hospital in 2022.” Jurnal Ilmiah Farmasi Farmasyifa 7 (2): 106–16. https://doi.org/10.29313/jiff.v7i2.3395.

Yusransyah, Yusransyah, Yuni Rahmawati, Baha Udin, and Nia Marlina Kurnia. 2023. “Cost-Effectiveness Analysis of Ceftriaxone and Cefixime in Typhoid Fever Patients Hospitalized at Berkah Pandeglang Regional Hospital for the Period 2020-2021.” Jurnal Farmasi Sains dan Praktis 9 (2): 178–84. https://doi.org/10.31603/pharmacy.v9i2.8648.

Zuhdi, Alif Tibia, Sarniwaty Kamissy, Tri Setyawati, and Imtihanah Amri. 2024. “Demam Tifoid pada Remaja Laki-Laki Usia 18 Tahun (Typhoid Fever in an 18-Year-Old Male Adolescent).” Jurnal Medical Profession (Medpro) 6 (2): 143–51.

DOI: http://dx.doi.org/10.52365/jecp.v5i2.1436